Prostate Cancer and Prostatic Diseases

(ISSN: 1365-7852, 1476-5608)

This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.

Articles Available on Medscape

 
 

Table of Contents

From Prostate Cancer and Prostatic Diseases

2020 - 23 (2)

  • Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis. 
  • Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study. 
  • Adverse events related to abiraterone and enzalutamide treatment: analysis of the EudraVigilance database and meta-analysis of registrational phase III studies. 
 
 

Journal Information

Mission Statement: Prostate Cancer and Prostatic Diseases, covering all aspects of prostate disease (including BPH and cancer).